August 26, 2002
In Print Photo by Steve Gilbert Focus: Resistance Mutation Pinpointed in Gleevec Patients The discovery of a genetic mutation that makes some patients with chronic myelogenous leukemia resistant to the touted drug Gleevec may ultimately save these patients. The study by Richard Van Etten and colleagues also suggests that a combination therapy such as that against HIV, which targets multiple molecular targets, may be effective against this disease. BBS Bulletin HMI World HSTconnector InteliHealth MD-PhD Newsletter MedEd News Mentations On The Brain		Headlines Potential Cause of Arthritis Discovered Gleevec Shrinks Tumors in Over Half of Patients with Incurable Stomach Cancer Scientists Discover Chemical Switch that Determines Muscle Fiber Type Upcoming Mental Health Brown Bag: Anticipating the Anniversary of September 11 Nancy Costikyan, Harvard University Thursday, Sept. 5 12:00 p.m. Lab Works A multimedia site featuring Harvard Medical research		Spotlight Photo by Liza Green FUNC Adds Outreach to First-years' Repertoire Now in its fourth year, the First-year Urban Neighborhood Campaign (FUNC) took place the week before the opening of school, enabling first-year students to volunteer at community service projects throughout Boston. This year's organizer were second-year students Walter Bethune (above) and Jack Casey. Student Scene HMS Students, Fellows Aid Nepalis Toward Medical Ed Summit Esther Landhuis reports on a project in Nepal in which HMS grad students and postdocs are helping Nepali physicians establish a medical school outside of Kathmandu. What the Nepalis needed most was instructors in basic science. Enter HMS.

Calendar | Jobs | About HMS | Hospitals | Back Issues | Feedback | Home Copyright 2002 by the President and Fellows of Harvard College